GILEAD SCIENCES, INC.
GILD
46 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 16 10:02 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $123.92 | $371.8K | 124,234(D) | View → |
| Jun 15, 2026 | Jun 16 9:53 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $125.40 | $376.2K | 171,646(D) | View → |
| Jun 15, 2026 | Jun 15 8:30 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $125.40 | $376.2K | — | View → |
| Jun 15, 2026 | Jun 15 8:09 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $123.92 | $371.8K | — | View → |
| Jun 1, 2026 | Jun 2 10:04 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 15,000 | $131.46 | $2.0M | 617,567(D) | View → |
| Jun 1, 2026 | Jun 1 8:45 PM | DANIEL O'DAY | Proposed Sale | 35,000 | $134.43 | $4.7M | — | View → |
| May 15, 2026 | May 18 9:50 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $132.27 | $396.8K | 173,191(D) | View → |
| May 15, 2026 | May 18 9:45 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 28,000 | $131.29 | $3.7M | 125,779(D) | View → |
| May 15, 2026 | May 15 8:09 PM | JOHANNA MERCIER | Proposed Sale | 28,000 | $131.29 | $3.7M | — | View → |
| May 15, 2026 | May 15 8:07 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $132.27 | $396.8K | — | View → |
| Apr 28, 2026 | Apr 29 9:53 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 10,000 | $129.16 | $1.3M | 632,567(D) | View → |
| Apr 28, 2026 | Apr 28 8:12 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $129.16 | $1.3M | — | View → |
| Apr 15, 2026 | Apr 16 10:41 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $140.96 | $422.9K | 176,191(D) | View → |
| Apr 15, 2026 | Apr 16 10:40 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $140.96 | $422.9K | 128,779(D) | View → |
| Apr 15, 2026 | Apr 15 8:12 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $140.96 | $422.9K | — | View → |
| Apr 15, 2026 | Apr 15 8:08 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $140.96 | $422.9K | — | View → |
| Mar 27, 2026 | Mar 30 9:59 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 10,000 | $136.82 | $1.4M | 642,567(D) | View → |
| Mar 27, 2026 | Mar 27 8:03 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $136.82 | $1.4M | — | View → |
| Mar 16, 2026 | Mar 17 10:56 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $144.23 | $432.7K | 131,779(D) | View → |
| Mar 16, 2026 | Mar 17 10:14 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $144.23 | $432.7K | 179,191(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:37 PM | Erin BurkhartSVP, Controllership | Grant/Award | 7,810 | $148.56 | 5,455(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 20,026 | — | 68,044(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Grant/Award | 155,570 | $148.56 | 122,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Grant/Award | 39,890 | $148.56 | 31,475(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Option Exercise | 2,133 | — | 39,046(D) | View → |
| Feb 17, 2026 | Feb 18 10:22 PM | Johanna MercierChief Comm & Corp Aff Officer | Option Exercise | 25,000 | $66.64 | 48,110(D) | View → |
| Feb 5, 2026 | Feb 6 9:22 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 0(D) | View → |
| Jan 23, 2026 | Jan 27 12:29 AM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 115,640(D) | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Option Exercise | 5,000 | $67.45 | 4,665(D) | View → |
← Previous
Page 2 of 2